5-Iodotubercidin Inhibits the Growth of Insulinoma Cells by Inducing Apoptosis
Neuroendocrinology · 2023
DOI: 10.1159/000529616 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuroendocrinology, 2023. Verfasst von Biaolin Zheng und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China, zhengbiaolin@stu.gxmu.edu.cn. Hauptthemen laut MEDLINE: Insulinoma, Pancreatic Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Abstract (Originalsprache)
Introduction
5-Iodotubercidin, a type of purine derivative, has attracted increasing attention in tumor chemotherapy because of its potential as an antitumor agent in recent years. In this study, we confirmed the effects on apoptosis in insulinoma cell lines induced by 5-iodotubercidin and tried to illuminate the underlying mechanisms.
Methods
We used 5-iodotubercidin in the treatment of insulinoma cells and the cell proliferation was examined using CCK-8 assay, colony-forming assays, and insulinoma animal models. Cell apoptosis was examined using TUNEL assays and Western blotting. Cellular DNA damage was shown by comet assay and immunofluorescence. The expression of apoptosis-regulating proteins and DNA damage biomarker was investigated by Western blotting. Subcutaneous inoculation of the insulinoma cells into nude mice was to measure blood glucose, insulin levels, and tumor growth. ATM siRNA and p53 siRNA were used as loss-of-function targets to evaluate 5-iodotubercidin treatment.
Results
5-Iodotubercidin inhibited the proliferation of insulinoma cells and induced DNA damage and cell apoptosis. Moreover, 5-iodotubercidin induced ATM and p53 activated. In vivo, 5-iodotubercidin inhibited the growth of Ins-1 and Min-6 cells xenografts in nude mice.
Conclusion
5-Iodotubercidin induces DNA damage leading to insulinoma cells apoptosis by activating ATM/p53 pathway. Therefore, this is a potential strategy for treating insulinoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China, zhengbiaolin@stu.gxmu.edu.cn.
- Department of Gastroenterology, Guangxi Medical University, Nanning, China, zhengbiaolin@stu.gxmu.edu.cn.
- Department of Gastroenterology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
- Department of Gastroenterology, Guangxi Medical University, Nanning, China.
- Department of Gastroenterology, The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.
- Department of Gastroenterology, Liuzhou People's Hospital, Liuzhou, China.
Zitieren
APA
Zheng, B., Chen, X., Chen, F., Liao, X., Wang, F., Yang, Z., Yi, N., Shi, X., Qin, S., & Jiang, H. (2023). 5-Iodotubercidin Inhibits the Growth of Insulinoma Cells by Inducing Apoptosis. Neuroendocrinology. https://doi.org/10.1159/000529616
Vancouver
Zheng B, Chen X, Chen F, Liao X, Wang F, Yang Z, et al. 5-Iodotubercidin Inhibits the Growth of Insulinoma Cells by Inducing Apoptosis. Neuroendocrinology. 2023. doi:10.1159/000529616
BibTeX
@article{Zheng2023,
author = {Zheng, Biaolin and Chen, Xiubing and Chen, Fengping and Liao, Xiaomin and Wang, Feng and Yang, Zhe and Yi, Nan and Shi, Xiaoyan and Qin, Shanyu and Jiang, Haixing},
title = {5-Iodotubercidin Inhibits the Growth of Insulinoma Cells by Inducing Apoptosis},
journal = {Neuroendocrinology},
year = {2023},
doi = {10.1159/000529616}
}
EUVIMED